Results 1 to 10 of about 4,593,278 (410)

Neoadjuvant therapy for melanoma: rationale for neoadjuvant therapy and pivotal clinical trials [PDF]

Therapeutic Advances in Medical Oncology, 2022
The treatment of malignant melanoma has drastically changed over the past decade with the advent of immune checkpoint blockade, targeted therapy with BRAF/MEK inhibition, and other novel therapies such as oncolytic virus intralesional therapy. Despite improvements in patient response rates and survival with these new treatments, there exists a large ...
Russell G. Witt, Derek J. Erstad, Jennifer A. Wargo   +2 more
openaire   +4 more sources

Neoadjuvant therapy for pancreatic cancer [PDF]

Updates in Surgery, 2021
Multimodal treatment including surgery and chemotherapy is considered the gold standard treatment of pancreatic cancer by most guidelines. Neoadjuvant therapy (NAT) has been seen as a possible treatment option for resectable, borderline resectable and locally advanced PaC.
Jean Gugenheim, Anna Crovetto, Niccolo Petrucciani   +2 more
openaire   +3 more sources

Neoadjuvant Therapy for Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma, 2022
Hepatocellular carcinoma (HCC) is characterized by low resection and high postoperative recurrence rates, and conventional treatment strategies have failed to meet clinical needs. Neoadjuvant therapy (NAT) is widely employed in the routine management of several solid tumors because it increases resectability and reduces the rate of postoperative ...
Yin,Zongyi, Chen,Dongying, Liang,Shuang, Li,Xiaowu   +3 more
openaire   +5 more sources

Neoadjuvant therapy for breast cancer [PDF]

Tumori Journal, 2019
Objective: To evaluate the frequency of neoadjuvant therapy (NT) in women with stage I–III breast cancer in Italy and whether it is influenced by biological characteristics, screening history, and geographic area.
Carrozzi G., Filiberti R. A., Giorgi Rossi P., Iacovacci S., Mancuso P., Mangone L., Mazzucco W., Minicozzi P., Sant M., Tagliabue G., Tumino R.   +10 more
core   +4 more sources

Adjuvant and neoadjuvant therapies in melanoma [PDF]

ESMO Open, 2020
Click here to listen to the Podcast.
Kok Haw Jonathan Lim, Teresa Amaral
openaire   +6 more sources

Long-term oncological outcomes of a phase II trial of neoadjuvant chemohormonal therapy followed by radical prostatectomy for patients with clinically localised, high-risk prostate cancer. [PDF]

, 2015
OBJECTIVE: To determine long-term oncological outcomes of radical prostatectomy (RP) after neoadjuvant chemohormonal therapy (CHT) for clinically localised, high-risk prostate cancer.
Basch, Bolla, Carlson, Chi, De Bono, Eastham, Garzotto, Gleave, Hugosson, Kattan, Klotz, Konety, Mellado, Mohler, Montie, Motzer, Petrylak, Prayer-Galetti, Sella, Siegel, Soloway, Soloway, Stephenson, Vickers, Walsh, Yee, Yossepowitch   +26 more
core   +2 more sources

Immunonutrition before esophagectomy: Impact on immune surveillance mechanisms [PDF]

, 2017
Preoperative oral immunonutrition was demonstrated to improve immune response and to decrease the infection rate in patients with cancer. This study aimed to assess how immunonutrition could influence the immune cell response in the mucosal ...
Agostini, Marco, Alfieri, Rita, Cagol, Matteo, Castagliuolo, Ignazio, Castoro, Carlo, Cavallin, Francesco, Fassan, Matteo, Kotsafti, Andromachi, Nardi, Teresa, Pinto, Eleonora, Rugge, Massimo, Scarpa, Marco, Scarpa, Melania   +12 more
core   +1 more source

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with HER2-positive breast cancer [PDF]

, 2015
Neoadjuvant chemotherapy plus trastuzumab (NCT) increases the rate of pathological complete response (pCR) and event-free survival (EFS) compared to neoadjuvant chemotherapy (NC) alone in women with HER2 positive breast cancer (BC).
Ades, F, Ahmed, R, Asher, R, Beresford, M, De Azambuja, E, Gojis, O, Howell, SJ, Januszewski, A, Lewanski, C, Lythgoe, D, Macpherson, IRJ, Owadally, W, Palmieri, C, Riddle, P, Shah, D, Stanley, B, Yan, K   +16 more
core   +2 more sources

Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer) [PDF]

, 2009
A German working group of 23 breast cancer experts discussed the results from the vote at this year's St. Gallen Consensus Conference on Primary Therapy for Early Breast Cancer ( March 11-14, 2009) and came up with some concrete recommendations for day ...
Beckmann, Matthias W., Blohmer, Jens-Uwe, Costa, Serban-Dan, Diedrich, Klaus, Diel, Ingo, Eiermann, Wolfgang, Friese, Klaus, Gerber, Bernd, Harbeck, Nadia, Hilfrich, Joern, Jaenicke, Fritz, Janni, Wolfgang, Jonat, Walter, Kaufmann, Manfred, Kiechle, Marion, Koehler, Uwe, Kreienberg, Rolf, Minckwitz, Gunter von, Moebus, Volker, Nitz, Ulrike, Schneeweiss, Andreas, Thomssen, Christoph, Wallwiener, Diethelm   +22 more
core   +2 more sources

Magnetic resonance imaging tumor regression shrinkage patterns after neoadjuvant chemotherapy in patients with locally advanced breast cancer: correlation with tumor biological subtypes and pathological response after therapy [PDF]

, 2017
The objective of this study is to analyze magnetic resonance imaging shrinkage pattern of tumor regression after neoadjuvant chemotherapy and to evaluate its relationship with biological subtypes and pathological response.
Anastasi, Emanuela, Ballesio, Laura, Catalano, Carlo, DI PASTENA, Francesca, Gigli, Silvia, Giraldi, Guglielmo, Manganaro, Lucia   +6 more
core   +1 more source